Mod­er­na’s mpox vac­cine out­per­forms ap­proved ver­sion in pre­clin­i­cal study

Pre­clin­i­cal da­ta sug­gest that Mod­er­na’s mpox vac­cine could be su­pe­ri­or to oth­er al­ter­na­tives cur­rent­ly ap­proved, ac­cord­ing to new re­search pub­lished Wednes­day.

Sci­en­tists

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER